Amneal Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMRX and other ETFs, options, and stocks.

About AMRX

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. 

CEO
Chintu Patel
CEOChintu Patel
Employees
8,500
Employees8,500
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
2002
Founded2002
Employees
8,500
Employees8,500

AMRX Key Statistics

Market cap
3.98B
Market cap3.98B
Price-Earnings ratio
56.54
Price-Earnings ratio56.54
Dividend yield
Dividend yield
Average volume
1.41M
Average volume1.41M
High today
$12.66
High today$12.66
Low today
$12.30
Low today$12.30
Open price
$12.32
Open price$12.32
Volume
644.63K
Volume644.63K
52 Week high
$15.42
52 Week high$15.42
52 Week low
$6.79
52 Week low$6.79

Stock Snapshot

As of today, Amneal Pharmaceuticals(AMRX) shares are valued at $12.66. The company's market cap stands at 3.98B, with a P/E ratio of 56.54.

As of 2026-04-13, Amneal Pharmaceuticals(AMRX) stock has fluctuated between $12.30 and $12.66. The current price stands at $12.66, placing the stock +2.9% above today's low and 0.0% off the high.

The Amneal Pharmaceuticals(AMRX)'s current trading volume is 644.63K, compared to an average daily volume of 1.41M.

In the last year, Amneal Pharmaceuticals(AMRX) shares hit a 52-week high of $15.42 and a 52-week low of $6.79.

In the last year, Amneal Pharmaceuticals(AMRX) shares hit a 52-week high of $15.42 and a 52-week low of $6.79.

AMRX News

Simply Wall St 2d
Should Amneal’s New Generic Glaucoma Launch Shape How AMRX Investors View Its Specialty Strategy?

On 9 April 2026, Amneal Pharmaceuticals announced it had launched bimatoprost ophthalmic solution 0.01% in multiple vial sizes, a generic equivalent to Allergan...

Should Amneal’s New Generic Glaucoma Launch Shape How AMRX Investors View Its Specialty Strategy?
Simply Wall St 4d
Is It Time To Reassess Amneal Pharmaceuticals After Its Strong Multi Year Share Price Run?

If you are wondering whether Amneal Pharmaceuticals' current share price reflects its true worth, the recent returns give you plenty to think about. The stock...

Is It Time To Reassess Amneal Pharmaceuticals After Its Strong Multi Year Share Price Run?

People also own

Based on the portfolios of people who own AMRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.